Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 57


Serological Epithelial Component Proteins Identify Intestinal Complications in Crohn's Disease.

Yau YY, Leong RWL, Pudipeddi A, Redmond D, Wasinger VC.

Mol Cell Proteomics. 2017 Jul;16(7):1244-1257. doi: 10.1074/mcp.M116.066506. Epub 2017 May 10.


The effect of iron balance on platelet counts in blood donors.

Eder AF, Yau YY, West K.

Transfusion. 2017 Feb;57(2):304-312. doi: 10.1111/trf.13881. Epub 2016 Nov 29.


Hematopoietic progenitor cell mobilization is more robust in healthy African American compared to Caucasian donors and is not affected by the presence of sickle cell trait.

Panch SR, Yau YY, Fitzhugh CD, Hsieh MM, Tisdale JF, Leitman SF.

Transfusion. 2016 May;56(5):1058-65. doi: 10.1111/trf.13551.


Plant artificial chromosome technology and its potential application in genetic engineering.

Yu W, Yau YY, Birchler JA.

Plant Biotechnol J. 2016 May;14(5):1175-82. doi: 10.1111/pbi.12466. Epub 2015 Sep 15. Review.


CRISPR-Cas9 Based Genome Engineering: Opportunities in Agri-Food-Nutrition and Healthcare.

Rajendran SR, Yau YY, Pandey D, Kumar A.

OMICS. 2015 May;19(5):261-75. doi: 10.1089/omi.2015.0023. Epub 2015 Apr 14. Review.


Long-term in vivo electromechanical reshaping for auricular reconstruction in the New Zealand white rabbit model.

Badran KW, Manuel CT, Loy AC, Conderman C, Yau YY, Lin J, Tjoa T, Su E, Protsenko D, Wong BJ.

Laryngoscope. 2015 Sep;125(9):2058-66. doi: 10.1002/lary.25237. Epub 2015 Mar 16.


Reverse-polynomial dilution calibration methodology extends lower limit of quantification and reduces relative residual error in targeted peptide measurements in blood plasma.

Yau YY, Duo X, Leong RW, Wasinger VC.

Mol Cell Proteomics. 2015 Feb;14(2):441-54. doi: 10.1074/mcp.M114.040790. Epub 2014 Dec 9.


An open-source system for in planta gene stacking by Bxb1 and Cre recombinases.

Hou L, Yau YY, Wei J, Han Z, Dong Z, Ow DW.

Mol Plant. 2014 Dec;7(12):1756-65. doi: 10.1093/mp/ssu107. Epub 2014 Oct 3.


Bimodal plasma metabolomics strategy identifies novel inflammatory metabolites in inflammatory bowel diseases.

Yau YY, Leong RW, Shin S, Bustamante S, Pickford R, Hejazi L, Campbell B, Wasinger VC.

Discov Med. 2014 Sep;18(98):113-24.


Initial serum ferritin predicts number of therapeutic phlebotomies to iron depletion in secondary iron overload.

Panch SR, Yau YY, West K, Diggs K, Sweigart T, Leitman SF.

Transfusion. 2015 Mar;55(3):611-22. doi: 10.1111/trf.12854. Epub 2014 Sep 11.


Mobilization characteristics and strategies to improve hematopoietic progenitor cell mobilization and collection in patients with chronic granulomatous disease and severe combined immunodeficiency.

Panch SR, Yau YY, Kang EM, De Ravin SS, Malech HL, Leitman SF.

Transfusion. 2015 Feb;55(2):265-74. doi: 10.1111/trf.12830. Epub 2014 Aug 21.


Heme-bound iron activates placenta growth factor in erythroid cells via erythroid Kr├╝ppel-like factor.

Wang X, Mendelsohn L, Rogers H, Leitman S, Raghavachari N, Yang Y, Yau YY, Tallack M, Perkins A, Taylor JG 6th, Noguchi CT, Kato GJ.

Blood. 2014 Aug 7;124(6):946-54. doi: 10.1182/blood-2013-11-539718. Epub 2014 Jun 10.


Skin autofluorescence associates with vascular calcification in chronic kidney disease.

Wang AY, Wong CK, Yau YY, Wong S, Chan IH, Lam CW.

Arterioscler Thromb Vasc Biol. 2014 Aug;34(8):1784-90. doi: 10.1161/ATVBAHA.114.303378. Epub 2014 May 29.


Less is more: strategies to remove marker genes from transgenic plants.

Yau YY, Stewart CN Jr.

BMC Biotechnol. 2013 Apr 23;13:36. doi: 10.1186/1472-6750-13-36. Review.


Ascertainment of iron deficiency and depletion in blood donors through screening questions for pica and restless legs syndrome.

Bryant BJ, Yau YY, Arceo SM, Hopkins JA, Leitman SF.

Transfusion. 2013 Aug;53(8):1637-44. doi: 10.1111/trf.12061. Epub 2013 Jan 10.


The Bxb1 recombination system demonstrates heritable transmission of site-specific excision in Arabidopsis.

Thomson JG, Chan R, Smith J, Thilmony R, Yau YY, Wang Y, Ow DW.

BMC Biotechnol. 2012 Mar 21;12:9. doi: 10.1186/1472-6750-12-9.


Changes in exercise capacity in subjects with cardiac asymptomatic hereditary hemochromatosis during a follow-up after 5 yrs.

Shizukuda Y, Smith KP, Tripodi DJ, Arena R, Yau YY, Bolan CD, Waclawiw MA, Leitman SF, Rosing DR.

Am J Phys Med Rehabil. 2012 May;91(5):418-24. doi: 10.1097/PHM.0b013e3182465f5f.


Iron replacement therapy in the routine management of blood donors.

Bryant BJ, Yau YY, Arceo SM, Daniel-Johnson J, Hopkins JA, Leitman SF.

Transfusion. 2012 Jul;52(7):1566-75. doi: 10.1111/j.1537-2995.2011.03488.x. Epub 2011 Dec 29.


Incidence of cardiac arrhythmias in asymptomatic hereditary hemochromatosis subjects with C282Y homozygosity.

Shizukuda Y, Tripodi DJ, Zalos G, Bolan CD, Yau YY, Leitman SF, Waclawiw MA, Rosing DR.

Am J Cardiol. 2012 Mar 15;109(6):856-60. doi: 10.1016/j.amjcard.2011.11.011. Epub 2011 Dec 22.


Changes in left ventricular diastolic function of asymptomatic hereditary hemochromatosis subjects during five years of follow-up.

Shizukuda Y, Tripodi DJ, Sachdev V, Brenneman CL, Sidenko S, St Peter M, Bolan CD, Yau YY, Leitman SF, Waclawiw MA, Rosing DR.

Am J Cardiol. 2011 Dec 15;108(12):1796-800. doi: 10.1016/j.amjcard.2011.07.054. Epub 2011 Sep 16.


Supplemental Content

Support Center